HCA

HCA Healthcare
D

HCA

Arincen59/100B

HCA Healthcare financials

Yes. HCA Healthcare earned 6.78B USD of net income over the last twelve months, 8.6% of its revenue. It made a profit in 35 of its 36 fiscal years since 1990. Its last loss was in fiscal year 1997.

Revenue (TTM)
78.70B USD
Net income (TTM)
6.78B USD
Free cash flow (TTM)
5.97B USD
Cash and short-term investments
908.00M USD
Total debt
52.43B USD
Shareholders' equity
-8.08B USD

Cash, debt and equity as of 30 Sept 2026.

HCA Healthcare earnings

Next earnings · Q4 FY2026
EPS estimate
8.15 USD
Revenue estimate
20.02B USD
Last quarter · Q3 FY2026
EPS7.22Beat +8.6%Revenue19.85BBeat +2.7%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q3 FY20277.40——+2.50%20.58B——+3.66%
Q2 FY20277.54——-0.70%20.36B——+0.63%
Q1 FY20277.49——+4.76%19.91B——+4.17%
Q4 FY20268.15——+1.75%20.02B——+2.58%
Q3 FY20266.657.22+8.57%+3.74%19.33B19.85B+2.70%+3.59%
Q2 FY20267.567.59+0.40%+10.96%19.76B20.23B+2.40%+8.73%
Q1 FY20267.127.15+0.42%+10.85%19.09B19.11B+0.11%+4.30%
Q4 FY20257.468.01+7.37%+28.78%19.68B19.51B-0.87%+6.72%
Q3 FY20255.796.96+20.21%+38.37%18.60B19.16B+3.02%+9.57%
Q2 FY20256.296.84+8.74%+23.69%18.50B18.61B+0.57%+6.36%

HCA Healthcare growth and profitability

Full income statement
Revenue (TTM)
78.70B USD
Net income (TTM)
6.78B USD
Gross margin
21.69%
Operating margin
15.34%
Net margin
8.61%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY202575.60B+7.08%6.78B+17.78%41.50%15.83%8.97%15.60B+12.28%
FY202470.60B+8.67%5.76B+9.88%40.62%14.94%8.16%13.90B+9.24%
FY202364.97B+7.86%5.24B-7.11%39.37%14.82%8.07%12.72B-4.28%
FY202260.23B+2.52%5.64B-18.88%38.48%15.03%9.37%13.29B-6.75%
FY202158.75B+14.01%6.96B+85.30%38.28%16.47%11.84%14.25B+46.40%

How HCA Healthcare makes its money

Revenue75.60B 100.0%
Cost of revenue44.23B 58.5%
Gross profit31.37B 41.5%
Selling and administration8.00B 10.6%
Other operating expenses11.41B 15.1%
Operating income11.97B 15.8%
Tax2.05B 2.7%
Other expense3.13B 4.1%
Net income6.78B 9.0%

FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.

HCA Healthcare revenue breakdown

By product

FY2025
Managed Care And Other Insurers: 50.5%Managed Medicare: 18.4%Medicare: 15.4%Medicaid: 8.1%Managed Medicaid: 5.0%International: 2.5%50.5%Managed Care And Other Insurers18.4%Managed Medicare15.4%Medicare8.1%Medicaid5.0%Managed Medicaid2.5%International
SegmentRevenueShare of revenueChange on the year
Managed Care And Other Insurers36.97B50.5%+5.8%
Managed Medicare13.44B18.4%+12.1%
Medicare11.27B15.4%+4.6%
Medicaid5.91B8.1%+26.3%
Managed Medicaid3.69B5.0%-7.2%
International1.86B2.5%+10.8%

By region

FY2025
American Group: 36.5%Atlantic Group: 34.1%National Group: 29.4%36.5%American Group34.1%Atlantic Group29.4%National Group
RegionRevenueShare of revenueChange on the year
American Group26.45B36.5%+7.5%
Atlantic Group24.71B34.1%+6.6%
National Group21.28B29.4%+8.5%

Operating and free cash flow

Full cash flow statement
Operating cash flow Free cash flow
Fiscal yearOperating cash flowFree cash flow
FY202512.64B7.69B
FY202410.51B5.64B
FY20239.43B4.69B
FY20228.52B4.13B
FY20218.96B5.38B
FY20209.23B6.40B
FY20197.60B3.44B
FY20186.76B3.19B
FY20175.43B2.41B
FY20165.65B2.89B

HCA Healthcare financial health

Full balance sheet
Cash and short-term investments
908.00M USD
Total debt
52.43B USD
Net cash
-51.52B USD
Free cash flow (TTM)
5.97B USD
Current ratio
0.82
Piotroski score
6 / 9
Altman Z-score
2.57

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY20251.04B50.20B7.69B
FY20242.02B45.24B5.64B
FY2023935.00M41.86B4.69B
FY2022908.00M40.20B4.13B
FY20211.45B36.73B5.38B

Assets, liabilities and equity

Total assets Total liabilities Shareholders' equity
Fiscal yearTotal assetsTotal liabilitiesShareholders' equity
FY202560.72B63.49B-6.03B
FY202459.51B58.96B-2.50B
FY202356.21B55.15B-1.77B
FY202252.44B52.51B-2.77B
FY202150.74B49.25B-933.00M
FY202047.49B44.60B572.00M
FY201945.06B45.62B-2.81B
FY201839.21B42.13B-4.95B
FY201736.59B41.59B-6.81B
FY201633.76B39.39B-7.30B

HCA Healthcare valuation

Price to earnings ratio (TTM)
16.35
Forward P/E (FY2026)
16.44
Price to sales (TTM)
1.31
EV / EBITDA (TTM)
9.74

Capital structure

Market capitalization
103.41B USD
+
Total debt
52.43B USD
−
Cash and short-term investments
908.00M USD
=
Enterprise value
154.92B USD

Valuation over time

P/EForward P/EForward P/E · EstimateEstimate
Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
FY2028 (est.)14.17————
FY2027 (est.)15.8014.17———
FY2026 (est.)16.4415.80———
Now (TTM)16.3515.891.31—9.74
FY202516.3115.511.42-17.8710.05
FY202413.4810.851.10-31.068.70
FY202314.0712.361.13-41.569.01
FY202212.3413.181.16-25.188.20
FY202111.949.221.41-89.038.30

HCA Healthcare against its own history

Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: Tenet Healthcare, Encompass Health, DaVita, and The Ensign Group, the US Medical - Care Facilities companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • P/E (today)Above its median16.4
    7.619.7
  • Gross marginHighest in 5 years41.5%
    38.3%41.5%
    Against its peers: 3 of 5Peers' median 35.1%
  • Operating marginAbove its median15.8%
    14.8%16.5%
    Against its peers: 3 of 5Peers' median 15.4%
  • Net marginAt its median9.0%
    8.1%11.8%
    Against its peers: 2 of 5Peers' median 6.7%
  • Free cash flow marginHighest in 5 years10.2%
    6.9%10.2%
    Against its peers: 2 of 5Peers' median 8.5%
  • Revenue growthBelow its median7.1%
    2.5%14.0%
    Against its peers: 3 of 5Peers' median 8.5%
  • EPS growthAbove its median29.0%
    -9.5%93.6%
    Against its peers: 1 of 5Peers' median 1.3%
  • Debt to EBITDAAt its median3.22×
    2.58×3.29×
    Against its peers: 3 of 5Peers' median 4.32×
  • Current ratioLowest in 5 years0.83
    0.831.41
    Against its peers: 5 of 5Peers' median 1.36

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

HCA Healthcare dividends

Annual dividend
3.12 USD
Dividend yield (indicated)
0.63%
Payout ratio
12.69%
Years of dividend growth
6
Frequency
Quarterly
Next payment
0.78 USD
Next ex-dividend date
15 Dec 2026
Next payment date
29 Dec 2026

Dividends per share

Year202520242023202220212020201920182012
Dividends per share2.882.642.402.241.920.431.601.404.50

HCA Healthcare ownership

Institutions
58.45%
Institutional holders
1,402 (-83)
Free float
66.82%

Who owns the shares

Institutions 58.5% Others 41.5%
As of 30 Jun 2026

Shares free to trade

Free float 139.59M shares ·66.8% Closely held 69.31M shares ·33.2%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Insider trading

QuarterPurchasesSalesShares acquiredShares disposed of
Q4 2026091.49M1.56M
Q3 2026000.007.77K
Q2 2026009.26K3.34K
Q1 2026012183.13M220.07M

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY2025230.71M230.71M-11.88%
FY2024258.60M261.81M-5.28%
FY2023272.40M276.41M-6.19%
FY2022290.35M294.67M-10.37%
FY2021323.32M328.75M-4.81%

Common questions about HCA Healthcare's financials

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.